Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
Lolli C, Basso U, Derosa L, Scarpi E, Sava T, Santoni M, Crabb SJ, Massari F, Aieta M, Conteduca V, Maruzzo M, La Russa F, Wheater M, Berardi R, Galli L, De Giorgi U.
Lolli C, et al. Among authors: maruzzo m.
Oncotarget. 2016 Aug 23;7(34):54564-54571. doi: 10.18632/oncotarget.10515.
Oncotarget. 2016.
PMID: 27409344
Free PMC article.